Intrexon Corporation (XON):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Intrexon Corporation (XON) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137766FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Intrexon Corporation (Intrexon) is a biotechnology company. The company develops solutions for current and looming challenges. It operates through divisions, such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therapeutic product candidates for lysosomal storage diseases, hematological disorders, metabolic diseases, infectious diseases, CNS diseases, and autoimmune disorders. The company’s UltraVector platform produces and optimizes thousands of custom, complex gene systems; mAbLogix platform enables production of B-cell libraries for discovery of antibodies. It offers RheoSwitch Therapeutic System for inducible expression of single/multi-gene systems through an activator ligand. Intrexon has facilities in Maryland, Virginia, North Carolina, and California. The company was formerly known as Genomatix Corporation. Intrexon is headquartered in Blacksburg, Virginia, the US.

Intrexon Corporation Key Recent Developments

Dec 17, 2013: Intrexon Strengthens Leadership in Company’s Rapidly Growing Health Sector
Dec 09, 2013: Synthetic Biologics and Intrexon Corporation Initiate Development of Novel Biologics for a Subset of Patients Suffering from Irritable Bowel Syndrome
Nov 18, 2013: Intrexon Appoints executives to expand European and Asian markets, accelerate technology platform development
Oct 22, 2013: ZIOPHARM and Intrexon Announce Presentation of Data Highlighting Regulated Gene Expression System in Tumor-Homing Mesenchymal Stem Cells
Oct 17, 2013: ZIOPHARM and Intrexon Announce Presentations at the 2013 AACR-NCI-EORTC International Conference

This comprehensive SWOT profile of Intrexon Corporation provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intrexon Corporation including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Intrexon Corporation – Key Information
Intrexon Corporation – Overview
Intrexon Corporation – Key Employees
Intrexon Corporation – Key Employee Biographies
Intrexon Corporation – Key Operational Heads
Intrexon Corporation – Major Products and Services
Intrexon Corporation – History
Intrexon Corporation – Company Statement
Intrexon Corporation – Locations And Subsidiaries
Intrexon Corporation – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intrexon Corporation – Business Description
Intrexon Corporation – Corporate Strategy
Intrexon Corporation – SWOT Analysis
SWOT Analysis – Overview
Intrexon Corporation – Strengths
Intrexon Corporation – Weaknesses
Intrexon Corporation – Opportunities
Intrexon Corporation – Threats
Intrexon Corporation – Key Competitors

Section 3 – Company Financial Performance Charts

Intrexon Corporation – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intrexon Corporation, Key Information
Intrexon Corporation, Key Ratios
Intrexon Corporation, Share Data
Intrexon Corporation, Major Products and Services
Intrexon Corporation, History
Intrexon Corporation, Key Employees
Intrexon Corporation, Key Employee Biographies
Intrexon Corporation, Key Operational Heads
Intrexon Corporation, Other Locations
Intrexon Corporation, Subsidiaries
Intrexon Corporation, Key Manufacturing facilities
Intrexon Corporation, Key Competitors
Intrexon Corporation, SWOT Analysis
Intrexon Corporation, Ratios based on current share price
Intrexon Corporation, Annual Ratios
Intrexon Corporation, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intrexon Corporation, Performance Chart
Intrexon Corporation, Ratio Charts

★海外企業調査レポート[Intrexon Corporation (XON):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Golden Agri-Resources Ltd:戦略・SWOT・企業財務分析
    Golden Agri-Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Agri-Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Electra Limited (ELTR):企業概要、財務及び戦略的SWOT分析
    Summary Electra Limited (Electra) is a construction company. The company provides solutions for real estate development. Electra’s areas of activities include contracting, building and infrastructure facility management, trade, real estate development and concessions. It offers planning and installa …
  • EnActen Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EnActen Corporation Mergers and …
  • Hecla Mining Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hecla Mining Company Mergers an …
  • Celator Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine and daunorubicin liposomal formulation, irinotecan HCI and floxuridine and hydrophobic docetaxel …
  • PT Indoritel Makmur Internasional Tbk (DNET):企業概要、財務及び戦略的SWOT分析
    Summary PT Indoritel Makmur Internasional Tbk (Indoritel) is an investment holding company. The company develops and provides IT solutions and services. It offers internet-related businesses that consist of information technology consulting services relating to internet infrastructure networks and n …
  • Ramco Cements Ltd.:企業の戦略・SWOT・財務分析
    SummaryRamco Cements Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Caithness Energy, L.L.C.:企業のM&A・提携動向(エネルギー分野)
    Summary Caithness Energy, L.L.C. (Caithness) is a power generating company that generates power through wind, natural gas, geothermal, hydroelectric, solar and coal. The company offers services such as asset management, operations and maintenance, and development support. It has equity investments i …
  • OTP Bank Nyrt. (OTP):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "OTP Bank Nyrt." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a …
  • Subaru Corporation (7270):企業の財務・戦略的SWOT分析
    Subaru Corporation (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Barclays Capital, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Barclays Capital, Inc. Mergers …
  • Zayo Group, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zayo Group, LLC Mergers and Acq …
  • Shanghai MicroPort Medical Group Co Ltd:企業のM&A・提携動向(医療機器分野)
    Summary Shanghai MicroPort Medical Group Co Ltd (MicroPort), formerly MicroPort Medical (Shanghai) Co., Ltd., a subsidiary of Otsuka Holdings Co Ltd, medical device company that offers cardiology products. The company’s products include drug-eluting coronary stent system, target eluting coronary ste …
  • University of Texas Southwestern Medical Center-医療機器分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • OSAKA Titanium Technologies Co., Ltd. (5726):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "OSAKA Titanium Technologies Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timet …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務分析
    SummaryTec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Novaliq GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops novel ophthalmic and dermatological products, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears, a pres …
  • AngioChem Inc.:製品開発パイプライン動向2015
    AngioChem Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘AngioChem Inc. - Product Pipeline Review - 2015’, provides an overview of the AngioChem Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic de …
  • Plexus Corp. (PLXS):企業の財務及び戦略的SWOT分析
    Plexus Corp. (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • RSA Insurance Group plc (formerly Royal and Sun Alliance Insurance Group Plc):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RSA Insurance Group plc (former …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆